242 related articles for article (PubMed ID: 9218841)
1. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
[TBL] [Abstract][Full Text] [Related]
3. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
[TBL] [Abstract][Full Text] [Related]
5. HLA class II alleles in Japanese patients with inflammatory bowel disease.
Yoshitake S; Kimura A; Okada M; Yao T; Sasazuki T
Tissue Antigens; 1999 Apr; 53(4 Pt 1):350-8. PubMed ID: 10323339
[TBL] [Abstract][Full Text] [Related]
6. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
[TBL] [Abstract][Full Text] [Related]
7. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
Okada Y; Yamazaki K; Umeno J; Takahashi A; Kumasaka N; Ashikawa K; Aoi T; Takazoe M; Matsui T; Hirano A; Matsumoto T; Kamatani N; Nakamura Y; Yamamoto K; Kubo M
Gastroenterology; 2011 Sep; 141(3):864-871.e1-5. PubMed ID: 21699788
[TBL] [Abstract][Full Text] [Related]
8. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
9. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.
Trachtenberg EA; Yang H; Hayes E; Vinson M; Lin C; Targan SR; Tyan D; Erlich H; Rotter JI
Hum Immunol; 2000 Mar; 61(3):326-33. PubMed ID: 10689124
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ: Celiac disease
Bosca-Watts MM; Minguez M; Planelles D; Navarro S; Rodriguez A; Santiago J; Tosca J; Mora F
World J Gastroenterol; 2018 Jan; 24(1):96-103. PubMed ID: 29358886
[TBL] [Abstract][Full Text] [Related]
11. Distinct associations of HLA class II genes with inflammatory bowel disease.
Toyoda H; Wang SJ; Yang HY; Redford A; Magalong D; Tyan D; McElree CK; Pressman SR; Shanahan F; Targan SR
Gastroenterology; 1993 Mar; 104(3):741-8. PubMed ID: 8440433
[TBL] [Abstract][Full Text] [Related]
12. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany.
Reinshagen M; Loeliger C; Kuehnl P; Weiss U; Manfras BJ; Adler G; Boehm BO
Gut; 1996 Apr; 38(4):538-42. PubMed ID: 8707084
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis.
Matsumura Y; Kinouchi Y; Nomura E; Negoro K; Kakuta Y; Endo K; Aizawa H; Takagi S; Takahashi S; Shimosegawa T
Tissue Antigens; 2008 May; 71(5):447-52. PubMed ID: 18416774
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis.
Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Ruiz-Morales JA; Higuera L; Cutiño T; Rodríguez-Pérez JM; Villarreal-Garza C; Granados J
Hum Immunol; 2003 Jan; 64(1):119-23. PubMed ID: 12507822
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
17. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients.
Lü M; Xia B
Int J Immunogenet; 2006 Feb; 33(1):37-40. PubMed ID: 16426241
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression.
Futami S; Aoyama N; Honsako Y; Tamura T; Morimoto S; Nakashima T; Ohmoto A; Okano H; Miyamoto M; Inaba H
Dig Dis Sci; 1995 Apr; 40(4):814-8. PubMed ID: 7720475
[TBL] [Abstract][Full Text] [Related]
20. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey.
Uyar FA; Imeryüz N; Saruhan-Direskeneli G; Ceken H; Ozdoğan O; Sahin S; Tözün N
Eur J Immunogenet; 1998 Aug; 25(4):293-6. PubMed ID: 9777329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
